• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2020 Fiscal Year Research-status Report

Study of ATRX mediated telomere maintenance in neuroblastoma by using genome editing technology (CRISPR/Cas9)

Research Project

Project/Area Number 18K15256
Research InstitutionResearch Institute for Clinical Oncology, Saitama Cancer Center

Principal Investigator

AKTER JESMIN  埼玉県立がんセンター(臨床腫瘍研究所), 臨床腫瘍研究所, 技師 (70795830)

Project Period (FY) 2018-04-01 – 2022-03-31
KeywordsNeuroblastoma / ATRX / Replication stress / G-quadruplex / p53
Outline of Annual Research Achievements

ATRX is a tumor suppressor gene, and its recurrent somatic mutations relate to older neuroblastoma (NB) patients with advanced stages. Recent reports indicate that ATRX deficiency has been linked to replication stress and DNA damage by way of G-quadruplex (G4) DNA secondary structure. Here we found that NB cells lacking ATRX depends on p53 deficiency to limit replication–fork progression and genomic instability.
Previously, we knocked out (KO) ATRX in MYCN amplified (NGP) and MYCN single copy (SK-N-AS) NB cells with wild type and mutant TP53, respectively, using CRISPR-Cas9 system. By in vitro analysis, ATRX loss results in increased expression of gamma-H2AX, indicating the accumulation of endogenous DNA damage in the ATRX KO NGP cells but not in SK-N-AS clones. Using a monoclonal antibody known to recognize G4 structures (1H6), we found that ATRX loss increased G4 formation only in ATRX KO NGP cells. Furthermore, lentiviral-mediated inactivation of p53 reduced the G4 accumulation in the ATRX KO NGP cells, suggesting that ATRX plays a role in maintaining genome integrity and p53 deficiency helps to release replication stress and DNA damage in NB cells featuring inactivated ATRX.

Current Status of Research Progress
Current Status of Research Progress

2: Research has progressed on the whole more than it was originally planned.

Reason

Current year, we have done several biological analysis by using ATRX knock-out clone in different NB cells. And we got some exciting data for our project. Start to prepare manuscript about ATRX project. That means experimental work is going well.

Strategy for Future Research Activity

1. Writing the manuscript for this project.
2. Submit the article in some reputed journal.
3. Preparation of additional experiment for possible reviewer comments.

Causes of Carryover

Because of novel corona virus, we couldn't present our study in different meetings. And also some experiment materials, we couldn't buy last fiscal time.
This year, we are going to submit our manuscript and add the remaining
amount in new fiscal year for article cost. And try to attend the national conference to present our data.

  • Research Products

    (1 results)

All 2020

All Presentation (1 results)

  • [Presentation] p53 deficiency limits ATRX loss induced replication stress and genome instability in neuroblastoma cells2020

    • Author(s)
      AKTER JESMIN
    • Organizer
      The 79th annual meeting of the Japanese Cancer Association

URL: 

Published: 2022-12-28  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi